PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 7, 2026Scientific Reports0 citationsOpen Access

Pharmacophore-driven kinase profiling applied to the PKIS2 chemogenomic dataset

RBRonan BureauJLJean-Luc LamotteBCBertrand Cuissart

Key Points

  • The aim is to develop a method for extracting pharmacophore hypotheses from a kinase dataset without prior ligand selection.
  • Used a chemogenomic dataset comprising 406 kinases and 645 compounds (PKIS2).
  • Introduced a metric called Normalized Enrichment Measure (NEM) for evaluating pharmacophores.
  • Identified pharmacophores linked to specific kinases and analyzed overlapping kinases based on metric values.
  • Evaluated results against biological datasets like ChEMBL, DrugBank, and others.
  • Identified pharmacophore hypotheses associated with specific kinase selectivity profiles.
  • Showed consistency of results with extensive biological datasets.
  • Provided insights into polypharmacological profiles across the kinase interaction landscape.

Abstract

We present a data-driven and unsupervised approach for extracting 3D pharmacophore hypotheses, without prior ligand selection, from a chemogenomic kinase dataset (406 kinases and 645 compounds, PKIS2). A metric called NEM for Normalized Enrichment Measure is introduced for each pharmacophore, which quantifies change in the proportion of active compounds consistent with the pharmacophore compared to the original dataset. Based on this metric, we can identify pharmacophores associated with specific kinases and, conversely, determine all kinases that share similar metric values. This approach enables the characterization of polypharmacological profiles linked to individual pharmacophore hypotheses. We further evaluate the consistency of our results with various biological datasets, including ChEMBL, DrugBank, LINCS, KINOMEscan, and Kinobeads, showing agreement across representative case studies. This study highlights the potential of our approach for elucidating relationships between pharmacophores and kinase selectivity profiles, providing a scalable framework for exploring kinase–ligand interaction landscapes.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Bureau et al. (2026) studied this question.

synapsesocial.com/papers/69abc0de5af8044f7a4e98behttps://doi.org/10.1038/s41598-026-42945-7
Ask AI
Helpful
Bookmark
Share
View Full Paper